Your session is about to expire
← Back to Search
Ultrasound Therapy
Low-intensity Pulsed Ultrasound for Scaphoid Nonunion Fracture (SNAPU Trial)
N/A
Waitlist Available
Led By Neil White, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 52 weeks
Summary
This trial is testing a device that uses gentle sound waves to help wrist bones heal faster. It targets patients with a specific type of wrist fracture that hasn't healed properly. The sound waves from the device stimulate bone cells to grow and repair the fracture more quickly.
Who is the study for?
This trial is for individuals with a scaphoid fracture older than 3 months showing non-union signs, who have agreed to surgical fixation. Participants must be able to use the LIPUS device post-surgery for 4-6 months. It's not for those with additional fractures in the same arm, certain bone diseases, active infections or conditions that could impair follow-up.
What is being tested?
The study tests if low-intensity pulsed ultrasound (LIPUS) can speed up bone healing after surgery in patients with non-healing scaphoid bones. Patients are randomly assigned to receive either LIPUS or a sham device without knowing which one they get.
What are the potential side effects?
While specific side effects of LIPUS aren't detailed here, similar devices typically have minimal risks which may include mild discomfort at the site of application.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 52 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 52 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Functional outcomes as measured by range of motion and grip strength
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active LIPUS UnitActive Control1 Intervention
Low-intensity pulsed ultrasound treatment 20 minutes/day until the fracture is deemed united clinically and on CT scan.
Group II: Sham LIPUS UnitPlacebo Group1 Intervention
Sham device treatment 20 minutes/day until the fracture is deemed united clinically and on CT scan.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Scaphoid Nonunion Fracture include surgical fixation, bone grafting, and Low-Intensity Pulsed Ultrasound (LIPUS). Surgical fixation involves stabilizing the fracture with screws or pins to promote proper alignment and healing.
Bone grafting adds new bone tissue to the fracture site, which helps bridge the gap and stimulate bone regeneration. LIPUS promotes bone healing by stimulating cellular activity and increasing blood flow to the fracture site, which accelerates the healing process.
These mechanisms are crucial for patients as they address the challenges of poor blood supply and delayed healing associated with scaphoid fractures, ultimately improving recovery outcomes.
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
808 Previous Clinical Trials
884,235 Total Patients Enrolled
Workers' Compensation Board, AlbertaOTHER
3 Previous Clinical Trials
555 Total Patients Enrolled
Calgary Orthopaedic Research and Education FundOTHER
3 Previous Clinical Trials
376 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Sham LIPUS Unit
- Group 2: Active LIPUS Unit
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger